PDX9228 and PDX4582 tumors exhibited high expression of CCL5 and CXCL5, respectively, two cytokines shown to mobilize MDSCs from the bone marrow and infiltrate at the tumor site [38,39]. The gene discussed is CCL5; the disease is neoplasm.